Discover 2,271 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,271
Active & Responsive
Study Comparing Local/ MAC Anesthesia in Lumbar Decompression
for
Lumbar Spinal Stenosis
Location: Redwood City CA
Sponsor: Stanford University
Sex: All
Age: 40 - 70+
Code: NCT04992572
Early_phase1, Recruiting
Active & Responsive
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
for
Alopecia Areata
Location: Fremont CA, Santa Clarita CA, Northridge CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 50
Code: NCT07533006
Phase2, Recruiting
Active & Responsive
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
for
Nonsegmental Vitiligo
Location: Fremont CA, Sacramento CA, Los Angeles CA,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT07108283
Phase2, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Fremont CA, Reno NV, Northridge CA, Los Angeles CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
for
Kidney Disease
Location: Fremont CA, Los Angeles CA, Orange CA, Boise ID,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06963827
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Palo Alto CA, Los Alamitos CA, Carlsbad CA, Kirkland WA,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase2, Recruiting
Active & Responsive
Paired Non-inferiority Study Comparing Overture Semi-automated Vitrification System ("DaVitri") to Standard Manual Process for Clinical Pregnancy Outcomes
for
Oocyte Cryopreservation
Location: Novato CA
Sponsor: Overture Life
Sex: Female
Age: 18 - 45
Code: NCT06853418
Recruiting
Active & Responsive
A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies
for
Muscular Atrophy, Spinal
Location: Palo Alto CA, New York NY, Boston MA
Sponsor: Biogen
Sex: Female
Age: 18 - 54
Code: NCT05789758
Recruiting
Active & Responsive
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
for
Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy,
Location: Palo Alto CA, Los Angeles CA, La Jolla CA,
Sponsor: Dyne Therapeutics
Sex: All
Age: 16+
Code: NCT07486934
Phase3, Recruiting
Active & Responsive
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
for
Relapsing Multiple Sclerosis,
Location: Palo Alto CA, Portland OR, Seattle WA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 55
Code: NCT04047628
Phase3, Recruiting
Active & Responsive
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for
Healthy
Location: Palo Alto CA, Lancaster CA, Loma Linda CA,
Sponsor: Pfizer
Sex: All
Age: 0 - 49
Code: NCT07160244
Phase3, Recruiting
Active & ResponsiveNew
Study of Oral Food Challenge Biomarkers (SAFER)
for
Allergy
Location: Palo Alto CA, Baltimore MD, New York NY
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 1 - 17
Code: NCT07279467
Recruiting
Active & Responsive
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
for
Age-Related Macular Degeneration
Location: Palo Alto CA, Los Angeles CA, Riverside CA, Portland OR,
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 50+
Code: NCT03178149
Phase1, Recruiting
Active & ResponsiveNew
SMILE Surgery in One Eye Compared to Ray Tracing-guided LASIK Surgery in the Fellow Eye
for
Myopia, Astigmatism
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 22 - 59
Code: NCT07721714
Recruiting
Active & Responsive
Plexaa For Preconditioning: Gender Affirming Mastectomy
for
Nipple Necrosis, Nipple Graft Loss
Location: Palo Alto CA
Sponsor: Plexaa Ltd
Sex: Female
Age: 18+
Code: NCT06502353
Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Palo Alto CA, Elk Grove CA, Woodland CA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Stanford CA, Los Angeles CA, Houston TX, Detroit MI,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07111520
Phase1, Phase2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Palo Alto CA, Los Angeles CA, Duarte CA, Long Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
Gastroschisis Outcomes of Delivery (GOOD) Study
for
Gastroschisis
Location: Stanford CA, Loma Linda CA, Portland OR,
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT02774746
Recruiting
Active & Responsive
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
for
Sickle Cell Disease
Location: Palo Alto CA, Los Angeles CA, St Louis MO, Columbus OH,